Equity Details
Price & Market Data
Price: $5.41
Daily Change: +$0.04 / 0.74%
Daily Range: $5.32 - $5.53
Market Cap: $2,020,503,168
Daily Volume: 982,095
Performance Metrics
1 Week: -4.08%
1 Month: -5.42%
3 Months: -12.18%
6 Months: -18.65%
1 Year: 13.18%
YTD: -22.16%
About Bausch Health Companies Inc. (BHC)
Explore the fundamentals of Bausch Health Companies Inc. (BHC). The stock is at 5.41, exhibiting a daily change of +$0.04 / 0.74%. Its market capitalization is 2,020,503,168. Performance metrics cover YTD and all monthly and weekly periods.
Company Details
Employees: 20300
Sector: Health technology
Industry: Pharmaceuticals: other
Country: Canada
Details
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.